Cytology and human papillomavirus testing on cytobrushing samples from patients with head and neck squamous cell carcinoma. Issue 22 (9th July 2014)

• Record Type: Journal Article
• Authors: Donà, Maria Gabriella; Giuliani, Massimo; Vocaturo, Amina; Spriano, Giuseppe; Pichi, Barbara; Rollo, Francesca; Ronchetti, Livia; Covello, Renato; Pescarmona, Edoardo; Benevolo, Maria
• Is Part Of: Cancer. Volume 120:Issue 22(2014)
• Page Start: 3477
• Page End: 3484
• Publication Date: 2014-07-09
• Subjects: Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.28909
• Languages: English
• ISSNs: 0008-543X

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="cncr28909-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>The increasing incidence of human papillomavirus (HPV)‐related head and neck squamous cell carcinoma (HNSCC) highlights the need for simple and effective tools to evaluate head and neck lesions and their HPV status. The main objective of the current study was to investigate the association between abnormal cytology and HPV infection, assessed on cytobrushing samples, and histologically confirmed HNSCC. Second, the authors attempted to investigate whether HPV status on cytobrushing samples reflected that of the tumoral tissue.</p> </sec> <sec id="cncr28909-sec-0002" sec-type="section"> <title>METHODS</title> <p>A total of 164 samples from HNSCC, nonmalignant lesions, or healthy mucosae of the oral cavity and oropharynx were collected by cytobrushing in PreservCyt solution and evaluated by liquid‐based cytology and Linear Array HPV genotyping test. All the findings from the cytologic samples were compared with those from the corresponding histologic samples.</p> </sec> <sec id="cncr28909-sec-0003" sec-type="section"> <title>RESULTS</title> <p>Patients with abnormal cytology had a significantly higher risk of having an HNSCC (odds ratio [OR], 9.18; 95% confidence inteval [95% CI], 3.27‐26.49). The association was stronger for oral cancer (OR, 10.86; 95% CI, 2.51‐51.06) than oropharyngeal cancer (OR, 8.45; 95% CI, 1.62‐49.82). HPV positivity in the oropharyngeal cytobrushing was associated with a nearly 5‐fold higher risk of having abnormal cytology (OR, 4.57; 95% CI, 1.57‐13.57) as well as histologically proven oropharyngeal cancer (OR, 5.09; 95% CI, 1.09‐31.61). Comparing the HPV status on cytologic and corresponding histologic samples from patients with HNSCC, we found that 90.4% of the cases were concordant (kappa, 0.796).</p> </sec> <sec id="cncr28909-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>Abnormal brushing cytology is strongly associated with a diagnosis of HNSCC, whereas HPV positivity on cytobrushing samples is only associated with oropharyngeal cancer. HPV testing on cytobrushing samples represents a valid option for the assessment of HPV infection in patients with oropharyngeal cancer. <bold><italic>Cancer</italic> 2014;120:3477–3484</bold>. © <italic>2014 American Cancer Society</italic>.</p> </sec> </abstract>